STOCK TITAN

Camtek Ltd (CAMT) director granted stock options and RSUs

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Stav Orit reported acquisition or exercise transactions in this Form 4 filing.

Camtek Ltd director Orit Stav received equity-based compensation consisting of 254 restricted stock units, each representing one ordinary share, and 571 stock options to buy ordinary shares at $147.8700 per share. Both the RSUs and options vest at the Company’s 2027 annual shareholder meeting, subject to continued service, and the options expire on July 29, 2033. After these awards, Stav is reported to hold 2,819 ordinary shares directly.

Positive

  • None.

Negative

  • None.
Insider Stav Orit
Role Director
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) F2, F3 571 $0.00 $0.00
Grant/Award Ordinary Shares F1 254 $0.00 $0.00
Holdings After Transaction: Stock Option (Right to Buy) — 571 shares (Direct); Ordinary Shares — 2,819 shares (Direct)
Footnotes (3)
  1. F1. The restricted stock units ("RSUs") reported herein represent a contingent right to receive one share of ordinary stock of Camtek Ltd (the "Company"). All 254 RSUs reported hereby will vest on the date of the Company's 2027 annual meeting of shareholders, subject to the Reporting Person's continued service through such vesting date.
  2. F2. The Reporting Person was granted stock options to purchase ordinary shares of Camtek Ltd (the "Company") subject to the Reporting Person's continued service through such vesting date.
  3. F3. The options will vest on the date of the Company's 2027 annual meeting of shareholders, subject to continued service through the vesting date.
Stock options granted 571 shares Stock options to purchase ordinary shares granted to Orit Stav on 2026-07-29
Option exercise price $147.8700 per share Exercise price for 571 stock options granted to Orit Stav
Option expiration date 2033-07-29 Expiration date of the stock options granted to Orit Stav
RSUs granted 254 units Restricted stock units representing a right to receive ordinary shares
RSU and option vesting 2027 annual meeting Both RSUs and options vest at the Company’s 2027 annual shareholder meeting
Ordinary shares after transaction 2,819 shares Total ordinary shares reported as directly held by Orit Stav after awards
restricted stock units ("RSUs") financial
"The restricted stock units ("RSUs") reported herein represent a contingent right"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
contingent right financial
"represent a contingent right to receive one share of ordinary stock"
vest financial
"All 254 RSUs reported hereby will vest on the date of the Company’s 2027 annual meeting"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
stock options financial
"The Reporting Person was granted stock options to purchase ordinary shares"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What equity awards did Camtek (CAMT) grant to director Orit Stav?

Camtek granted Orit Stav 254 restricted stock units, each representing one ordinary share, and 571 stock options to purchase ordinary shares at an exercise price of $147.8700 per share. Both awards were granted on July 29, 2026.

When will Orit Stav's new Camtek (CAMT) RSUs vest?

All 254 RSUs are scheduled to vest on the date of Camtek’s 2027 annual meeting of shareholders, provided Orit Stav continues serving through that date. The RSUs represent a contingent right to receive ordinary shares upon vesting.

What are the key terms of Orit Stav's Camtek (CAMT) stock options?

Orit Stav received 571 stock options to purchase ordinary shares at an exercise price of $147.8700 per share. These options will vest at Camtek’s 2027 annual shareholder meeting, subject to continued service, and they expire on July 29, 2033.

How many Camtek (CAMT) ordinary shares does Orit Stav hold after these awards?

Following the reported grants, Orit Stav is shown as directly holding 2,819 ordinary shares of Camtek. This figure reflects the total ordinary shares reported in the ownership column after the July 29, 2026 equity awards.

Were Orit Stav’s Camtek (CAMT) awards made under a Rule 10b5-1 trading plan?

The disclosure indicates the Rule 10b5-1 checkbox was not marked for these transactions, and no trading plan is mentioned in the footnotes. The entries are characterized as grant/award acquisitions of equity-based compensation rather than trades under a pre-arranged plan.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Stav Orit

(Last)(First)(Middle)
5 URI ARIAV STREET

(Street)
ROSH HAAIN

(City)(State)(Zip)

ISRAEL

(Country)
2. Issuer Name and Ticker or Trading Symbol
CAMTEK LTD [ CAMT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/29/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares07/29/2026A(1)254A$02,819D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$147.8707/29/2026A(2)571 (3)07/29/2033Ordinary Shares571$0571D
Explanation of Responses:
1. The restricted stock units ("RSUs") reported herein represent a contingent right to receive one share of ordinary stock of Camtek Ltd (the "Company"). All 254 RSUs reported hereby will vest on the date of the Company's 2027 annual meeting of shareholders, subject to the Reporting Person's continued service through such vesting date.
2. The Reporting Person was granted stock options to purchase ordinary shares of Camtek Ltd (the "Company") subject to the Reporting Person's continued service through such vesting date.
3. The options will vest on the date of the Company's 2027 annual meeting of shareholders, subject to continued service through the vesting date.
/s/ Meirav Shemesh on behalf of Oppenheimer Israel, as Attorney-in-fact07/30/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)